Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
Antiviral Research|December 5, 2024
Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4'-fluorouridineLeon Schrell, Hannah L Fuchs, Antje Dickmanns, et al.Molecular Cell|November 30, 2021
MYCN recruits the nuclear exosome complex to RNA polymerase II to prevent transcription-replication conflictsDimitrios Papadopoulos, Daniel Solvie, Apoorva Baluapuri, et al.Nature|March 22, 2019
Recruitment of BRCA1 limits MYCN-driven accumulation of stalled RNA polymeraseSteffi Herold, Jacqueline Kalb, Gabriele Büchel, et al.Virus Research|June 6, 2021
The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture modelsKim M Stegmann, Antje Dickmanns, Sabrina Gerber, et al.The EMBO Journal|July 24, 2021
Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodiesThomas Güttler, Metin Aksu, Antje Dickmanns, et al.EMBO Reports|August 1, 2022
Dipeptidyl peptidase 9 triggers BRCA2 degradation and promotes DNA damage repairOguz Bolgi, Maria Silva-Garcia, Breyan Ross, et al.Virology|June 25, 2025
Synergistic interference with SARS-CoV-2 replication by molnupiravir-derived N4-hydroxycytidine and inhibitors of CTP synthetase in cell cultureKim M Stegmann, Antje Dickmanns, Hannah L Fuchs, et al.Proceedings of the National Academy of Sciences of the United States of America|July 11, 2007
Aristolochic acid and the etiology of endemic (Balkan) nephropathyArthur P Grollman, Shinya Shibutani, Masaaki Moriya, et al.Nature|November 24, 2022
MYC multimers shield stalled replication forks from RNA polymeraseDaniel Solvie, Apoorva Baluapuri, Leonie Uhl, et al.Nature Cancer|March 26, 2021
Combined inhibition of Aurora-A and ATR kinase results in regression of MYCN-amplified neuroblastomaIsabelle Roeschert, Evon Poon, Anton G Henssen, et al.Pageof 11